Kizzmekia Corbett
#58,717
Most Influential Person Now
American immunologist
Kizzmekia Corbett's AcademicInfluence.com Rankings
Kizzmekia Corbettbiology Degrees
Biology
#3520
World Rank
#5374
Historical Rank
#1420
USA Rank
Immunology
#314
World Rank
#326
Historical Rank
#73
USA Rank
Virology
#379
World Rank
#387
Historical Rank
#56
USA Rank
Download Badge
Biology
Kizzmekia Corbett's Degrees
- Bachelors Biological Sciences University of Maryland, Baltimore County
- PhD Microbiology and Immunology University of North Carolina at Chapel Hill
Why Is Kizzmekia Corbett Influential?
(Suggest an Edit or Addition)According to Wikipedia, Kizzmekia "Kizzy" Shanta Corbett is an American viral immunologist. She is an Assistant Professor of Immunology and Infectious Diseases at Harvard T.H. Chan School of Public Health and the Shutzer Assistant Professor at the Harvard Radcliffe Institute since June 2021.
Kizzmekia Corbett's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation (2020) (6900)
- An mRNA Vaccine against SARS-CoV-2 — Preliminary Report (2020) (2366)
- Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults (2020) (1020)
- SARS-CoV-2 mRNA Vaccine Design Enabled by Prototype Pathogen Preparedness (2020) (846)
- Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen (2017) (837)
- Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates (2020) (809)
- Pre-fusion structure of a human coronavirus spike protein (2016) (630)
- Cryo-EM Structure of the 2019-nCoV Spike in the Prefusion Conformation (2020) (494)
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (443)
- Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (421)
- mRNA-1273 vaccine induces neutralizing antibodies against spike mutants from global SARS-CoV-2 variants (2021) (418)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants (2021) (322)
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine (2021) (286)
- The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates (2021) (270)
- Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates (2021) (176)
- Importance of Neutralizing Monoclonal Antibodies Targeting Multiple Antigenic Sites on the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein To Avoid Neutralization Escape (2018) (142)
- Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants (2021) (133)
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2021) (130)
- SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness (2020) (128)
- LY-CoV555, a rapidly isolated potent neutralizing antibody, provides protection in a non-human primate model of SARS-CoV-2 infection (2020) (127)
- Serum Neutralizing Activity Elicited by mRNA-1273 Vaccine - Preliminary Report. (2021) (119)
- Serologic cross-reactivity of SARS-CoV-2 with endemic and seasonal Betacoronaviruses (2020) (100)
- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron (2022) (98)
- Validation of a SARS-CoV-2 spike protein ELISA for use in contact investigations and serosurveillance (2020) (93)
- LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants (2022) (82)
- Primary Human mDC1, mDC2, and pDC Dendritic Cells Are Differentially Infected and Activated by Respiratory Syncytial Virus (2011) (75)
- Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (73)
- Design of Nanoparticulate Group 2 Influenza Virus Hemagglutinin Stem Antigens That Activate Unmutated Ancestor B Cell Receptors of Broadly Neutralizing Antibody Lineages (2019) (71)
- Structural Definition of a Neutralization-Sensitive Epitope on the MERS-CoV S1-NTD (2019) (69)
- Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (2020) (69)
- Serologic Cross-Reactivity of SARS-CoV-2 with Endemic and Seasonal Betacoronaviruses (2021) (69)
- Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice (2021) (68)
- mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron (2022) (65)
- Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates (2021) (62)
- Preexisting neutralizing antibody responses distinguish clinically inapparent and apparent dengue virus infections in a Sri Lankan pediatric cohort. (2015) (55)
- Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies (2018) (52)
- A Platform Incorporating Trimeric Antigens into Self-Assembling Nanoparticles Reveals SARS-CoV-2-Spike Nanoparticles to Elicit Substantially Higher Neutralizing Responses than Spike Alone (2020) (48)
- Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates (2021) (47)
- Erratum: Structural Basis for Potent Neutralization of Betacoronaviruses by Single-Domain Camelid Antibodies (Cell (2020) 181(5) (1004–1015.e15), (S0092867420304943), (10.1016/j.cell.2020.04.031)) (2020) (45)
- Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung (2021) (43)
- Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (41)
- Vaccination with Human Papillomavirus Pseudovirus-Encapsidated Plasmids Targeted to Skin Using Microneedles (2015) (40)
- mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates (2021) (40)
- Stabilized coronavirus spike stem elicits a broadly protective antibody (2021) (39)
- A platform incorporating trimeric antigens into self-assembling nanoparticles reveals SARS-CoV-2-spike nanoparticles to elicit substantially higher neutralizing responses than spike alone (2020) (38)
- COVID-19 vaccine mRNA-1273 elicits a protective immune profile in mice that is not associated with vaccine-enhanced disease upon SARS-CoV-2 challenge (2021) (36)
- Durability of mRNA-1273-induced antibodies against SARS-CoV-2 variants (2021) (35)
- Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates (2021) (35)
- Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates (2021) (32)
- Mucosal Delivery of Human Papillomavirus Pseudovirus-Encapsidated Plasmids Improves Potency of DNA Vaccination (2010) (31)
- Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses (2020) (30)
- Burden of dengue infection and disease in a pediatric cohort in urban Sri Lanka. (2014) (30)
- Antibodies with potent and broad neutralizing activity against antigenically diverse and highly transmissible SARS-CoV-2 variants (2021) (29)
- Report of the National Institutes of Health SARS-CoV-2 Antiviral Therapeutics Summit (2021) (26)
- Prototype pathogen approach for pandemic preparedness: world on fire. (2020) (25)
- Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes (2020) (21)
- Variant SARS-CoV-2 mRNA vaccines confer broad neutralization as primary or booster series in mice (2021) (21)
- Importance of neutralizing monoclonal antibodies targeting multiple antigenic sites on MERS-CoV Spike to avoid neutralization escape. (2018) (21)
- Newcastle Disease Virus-Like Particles Displaying Prefusion-Stabilized SARS-CoV-2 Spikes Elicit Potent Neutralizing Responses (2021) (20)
- SARS-CoV-2 vaccines elicit durable immune responses in infant rhesus macaques (2021) (19)
- Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates (2021) (11)
- SARS-CoV-2 Vaccines Elicit Durable Immune Responses in Infant Rhesus Macaques (2021) (11)
- Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway (2021) (10)
- LY-CoV1404 potently neutralizes SARS-CoV-2 variants (2021) (10)
- A high-throughput inhibition assay to study MERS-CoV antibody interactions using image cytometry (2018) (10)
- Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates (2021) (9)
- Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability (2022) (8)
- Prefusion coronavirus spike proteins and their use (2017) (8)
- Prefusion 2019-nCoV spike glycoprotein with a single receptor-binding domain up (2020) (6)
- Severe Acute Respiratory Syndrome Coronavirus 2 Prevalence, Seroprevalence, and Exposure among Evacuees from Wuhan, China, 2020 (2020) (4)
- The duty to mentor, be visible and represent (2020) (4)
- From mRNA sensing to vaccines (2021) (3)
- Voices of biotech research (2021) (3)
- Structure-Based Design with Tag-Based Purification and In-Process Biotinylation Enable Streamlined Development of SARS-CoV-2 Spike Molecular Probes. (2020) (3)
- Co-immunization with hemagglutinin stem immunogens elicits cross-group neutralizing antibodies and broad protection against influenza A viruses. (2022) (2)
- Receptor binding and proteolysis do not induce large conformational changes in the SARS-CoV spike (2018) (1)
- Infant rhesus macaques immunized against SARS-CoV-2 are protected against heterologous virus challenge one year later (2022) (1)
- Design of nanoparticulate group 2 influenza hemagglutinin stem antigens that activate unmutated ancestor B cell receptors of broadly neutralizing antibody lineages (2018) (1)
- Methods to Measure Antibody Neutralization of Live Human Coronavirus OC43 (2021) (1)
- Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (0)
- Characterization of Human Antibody Responses to Dengue Virus Infections in a Sri Lankan Pediatric Cohort (2014) (0)
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness (2020) (0)
- SARS-CoV-2 vaccines induce potent immune responses in infant rhesus macaques (2021) (0)
- Vaccine-elicitation of cross-group neutralizing protective antibodies to influenza A viruses (2022) (0)
- Vaccine-elicited murine antibody WS6 neutralizes diverse beta-coronaviruses by recognizing a helical stem supersite of vulnerability (2022) (0)
- SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness Preview (2020) (0)
- Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responses (2020) (0)
- Publisher Correction: Stabilized coronavirus spikes are resistant to conformational changes induced by receptor recognition or proteolysis (2018) (0)
- Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report (2022) (0)
- Title: Immune Correlates of Protection by mRNA-1273 Immunization against 1 SARS-CoV-2 Infection in Nonhuman Primates (2021) (0)
- Career advice from my father: “Go where you are loved” (2021) (0)
- Nanoparticle display of prefusion coronavirus spike elicits S1-focused cross-reactive protection across divergent subgroups (2022) (0)
- Efficacy of pediatric SARS-CoV-2 vaccines against high-dose B.1.617.2 challenge one year after vaccination of infant rhesus macaques (2022) (0)
This paper list is powered by the following services:
Other Resources About Kizzmekia Corbett
What Schools Are Affiliated With Kizzmekia Corbett?
Kizzmekia Corbett is affiliated with the following schools:
